Information Provided By:
Fly News Breaks for November 9, 2016
ENDP
Nov 9, 2016 | 07:40 EDT
UBS analyst Marc Goodman said the selloff in Endo following management comments about a decline in its generics business seems like an overreaction. The analyst feels if the company is unable to grow much over the next two years, the free cash flow will start to move to shareholders and should be good for the stock. Goodman lowered his price target to $28 from $30 on Endo shares but maintained his Buy rating.
News For ENDP From the Last 2 Days
There are no results for your query ENDP